NAD+
NAD+ is a cofactor involved in cellular energy reactions and enzyme activity. Research examines its metabolism and related pathways; measuring NAD+ metabolites does not by itself demonstrate more energy or slower aging.
Metabolic BlendIllustrative presentation
INFORMATIONAL REFERENCE
Metabolic Blend
This combination brings together NAD+, MOTS-c, 5-amino-1MQ. Explore each component’s research focus below, followed by the evidence for the combination.
Research focus & potential applications
MOTS-c
MOTS-c connects mitochondrial biology with metabolic signaling. Preclinical research explores insulin sensitivity and responses to metabolic stress, offering potential applications for study rather than established human benefits.
5-amino-1MQ
Researchers are exploring whether inhibiting NNMT could influence fat storage and cellular energy use. The potential application is metabolic health; the evidence discussed here is preclinical, so human weight-loss benefits remain unestablished.
What the research shows
Explore the selected studies, their findings and their limits.
NAD+
Read the findings & sources
Human study discussedA small human pilot tracked NAD+ and related metabolites in plasma and urine during an infusion. It helps describe how administered NAD+ is processed, rather than proving more energy, better cognition or slower aging. NAD+ itself, oral nicotinamide riboside and other precursors are different interventions; results cannot be exchanged between them.
MOTS-c
Read the findings & sources
Preclinical evidenceThe original MOTS-c study linked this mitochondrial-derived peptide to metabolic signaling in cells and mice. In high-fat-diet mouse experiments, researchers reported improved insulin sensitivity and protection against diet-related metabolic changes. These animal findings do not quantify human weight loss or demonstrate improved exercise capacity from administering MOTS-c to people.
5-amino-1MQ
Read the findings & sources
Preclinical evidenceA 2018 study tested this NNMT-inhibiting small molecule in fat cells and mice with diet-induced obesity. Researchers observed less lipid accumulation in cells and reductions in body weight and fat-tissue measures in mice. These experiments connect NNMT with energy metabolism; they do not establish a weight-loss percentage or long-term safety in people.
Evidence for the combination
The sources above examine individual constituents or related molecules. They do not test this exact combination. A combined effect, improved recovery or greater safety cannot be inferred by adding the individual findings together.
For more information, contact info@aurevixpeptides.com.
Editorial review: September 23, 2026